PMCB long on opening range breakout Long

PharmaCyte Biotech, Inc.NASDAQ

Description

⋅ Aug 18, 2021 2:35 PM

Stock screener showed PMCB as 2nd biggest pre-market gainer, but unlyike VRPX it did not stop at the pre-market high but continued trading higher.

Aiming for a 10$ target or higher...

Anyway a low risk / high reward play...

Support and Resistance